Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
58 hedge funds and large institutions have $192M invested in Oxford Immunotec Global PLC Ordinary Shares in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 12 reducing their positions, and 3 closing their positions.
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
108% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 12
23% more funds holding
Funds holding: 47 → 58 (+11)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
6% less capital invested
Capital invested by funds: $205M → $192M (-$13.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$6.05M |
| 2 |
DCC
Dow Chemical Company
Midland,
Michigan
|
+$4.96M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$3.55M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$3.31M |
| 5 |
O
OppenheimerFunds
New York
|
+$2.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.62M |
| 2 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
-$3.36M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$2.75M |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
-$1.73M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$740K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
51
Panagora Asset Management
Boston,
Massachusetts
| $18K | – | – | – |
|
|
MAA
52
Managed Account Advisors
Jersey City,
New Jersey
| $14K | -$54 | -3 | -0.4% |
|
53
Bank of America
Charlotte,
North Carolina
| $12K | +$12.4K | +688 | +5,733% |
|
54
Barclays
London,
United Kingdom
| $4K | -$32.7K | -1,815 | -88% |
|
55
Bank of Montreal
Toronto,
Ontario, Canada
| $3K | +$2.88K | +160 | New |
|
56
Citigroup
New York
| $2K | -$15.1K | -841 | -88% |
|
|
GSC
57
Ground Swell Capital
Folly Beach,
South Carolina
| $2K | +$1.84K | +102 | New |
|
58
Morgan Stanley
New York
| $1K | -$36 | -2 | -6% |
|
|
59
Fidelity Investments
Boston,
Massachusetts
| – | -$4.62M | -230,000 | Closed |
|
|
TCM
60
Tamarack Capital Management
Carlsbad,
California
| – | -$3.36M | -167,625 | Closed |
|
|
SO
61
STRS Ohio
Columbus,
Ohio
| – | -$50K | -2,500 | Closed |
|
OXFD Hedge Fund Activity: Q2 2014 in Review
58 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q2 2014, worth a combined $192M — down 6.4% from $205M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new OXFD positions and 3 closed out — a net gain of 12 holders — while 25 added to existing stakes and 12 trimmed.
The largest buyer was Redmile Group, adding an estimated $6.05M. The largest seller was Fidelity Investments, exiting entirely with an estimated $4.62M sold.
- 58 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q2 2014, up from 47 in Q1 2014.
- Funds reported $192M of Oxford Immunotec Global PLC Ordinary Shares stock for Q2 2014, down 6.4% quarter-over-quarter.
- 15 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q2 2014 and 3 closed out, a net change of +12 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q2 2014 was Redmile Group, an estimated $6.05M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q2 2014 was Fidelity Investments, an estimated $4.62M sold.
Based on aggregated 13F filings for Q2 2014.